Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
The Journal of Investigative Dermatology|August 16, 2025
Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-RSandra Garcet, Lam C Tsoi, Hong Hur, et al.Brain : a Journal of Neurology|May 18, 2026
Designing studies for post-treatment Lyme disease and other infection-associated chronic illnessesPaul M Arnaboldi, Jacqueline Becker, Avindra Nath, et al.The Journal of Allergy and Clinical Immunology|March 8, 2016
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitisPatrick M Brunner, Saakshi Khattri, Sandra Garcet, et al.The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.The Journal of Allergy and Clinical Immunology|August 6, 2019
Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitisKenji Sakurai, Teruki Dainichi, Sandra Garcet, et al.Experimental Dermatology|June 16, 2016
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisSaakshi Khattri, Patrick M Brunner, Sandra Garcet, et al.Allergy|March 7, 2026
The OX40/OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic DermatitisKazuhiko Yamamura, Dante Dahabreh, Ester Del Duca, et al.Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.The Journal of Investigative Dermatology|November 13, 2019
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic TherapyShunya Mashiko, Rebecca M Edelmayer, Yingtao Bi, et al.JAMA Dermatology|October 13, 2021
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical TrialKristina M Harris, Dawn E Smilek, Margie Byron, et al.Pageof 6